Cheryl Scott - 05 Jun 2025 Form 4 Insider Report for Evolent Health, Inc. (EVH)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
09 Jun 2025, 07:13:47 UTC
Prior SEC filing
28 May 2025
Next SEC filing
12 Jun 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Jonathan Weinberg, Attorney-in-fact

Key filing fact

Cheryl Scott filed Form 4 for Evolent Health, Inc. (EVH) on 09 Jun 2025.

Key facts

  • This page summarizes Cheryl Scott's Form 4 filing for Evolent Health, Inc. (EVH).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 09 Jun 2025, 07:13.

Change

  • Previous filing in this sequence was filed on 28 May 2025.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001656979 Primary reporting owner

Scott Cheryl

Relationship
Director
Address
C/O EVOLENT HEALTH, INC., 1812 N. MOORE ST., STE. 1705, ARLINGTON
Signature
/s/ Jonathan Weinberg, Attorney-in-fact
Signature date
09 Jun 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

EVH transaction

Class A Common Stock

Award

Transaction value
$0
Shares
+21,979
Change %
+43%
Price
$0.000000
Shares after
73,476
Date
05 Jun 2025
Ownership
Direct
Footnotes
F1, F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Represents restricted stock units granted to Ms. Scott pursuant to the Amended and Restated Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan.

Footnote F2

Securities vest on the earlier of June 5, 2026, and the date of the Company's 2026 annual meeting, subject to the reporting person's continued service on the vesting date.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .